89
Views
42
CrossRef citations to date
0
Altmetric
Original Article

Distribution and Prognosis of WHO Lymphoma Subtypes in Taiwan Reveals a Low Incidence of Germinal-Center Derived Tumors

, , , , &
Pages 1375-1384 | Received 04 Jan 2004, Published online: 03 Aug 2009

Reference

  • Parkin, D.M., Pisani, P. and Ferlay, J. (1999) "Global cancer statistics", CA Cancer J. Clin., 49(1), 33–64.
  • Anderson, J.R., Armitage, J.0. and Weisenburger, D.D. (1998) "Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project", Ann. Oncol., 9(7), 717 —720.
  • Su, I.J., Shih, L.Y., Kadin, M.E., Dun, P. and Hsu, S.M. (1985) "Pathologic and immunologic characterization of malignant lym-phoma in Taiwan. With special reference to retrovirus-associated adult T-cell lymphoma/leukemia", Am. J. Clin. PathoL, 84(6), 715 — 723.
  • Shih, L.Y. and Liang, D.C. (1991) "Non-Hodgkin's lymphomas in Asia", HematoL Oncol. Clin. North Am., 5(5), 983 — 1001.
  • Warnke, R.A., Weis, L.M., Chan, J.K.C., et al. (1995) Tumors of the Lymph Nodes and Spleen. 3rd edn. In Atlas of Tumor Pathology, edited by Rosai J. Pp. 54— 57. Washington, D.C.: AFIP.
  • Harris, N.L. (2000) Classification of lymphoid neoplasms. In Tutorial on neoplastic hematopathology. Miami, Vol. I, pp. 3–11. New York: Weill Medical College of Cornell University.
  • Frizzera, G. (1998) Classification of malignant lymphomas (Hand-out). In Annual congress of Taiwan Society of Pathology. Taipei, pp. 1–15. Taipei: Taiwan Society of Pathology.
  • Harris, N.L., Jaffe, ES., Stein, H., Banks, P.M., Chan, J.K., Cleary, ML., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood, 84(5), 1361–1392.
  • Harris, N.L., Jaffe, ES., Diebold, J., Flandrin, G., Muller-Hermelink, H.K. and Vardiman, J. (2000) "Lymphoma classifica-tion—from controversy to consensus: the REAL. and WHO Classification of lymphoid neoplasms", Ann. Oncol., 11\(Suppl 1), 3–10.
  • Krol, A.D., le Cessie, S., Snijder, S., Kluin-Nelemans, J.C., Kluin, P.M. and Noordijk, E.M. (2003) "Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry", Ann. Oncol., 14(1), 131–139.
  • Barrans, S.L., Carter, I., Owen, R.G., Davies, FE., Patmore, Haynes, A.P., et al. (2002) "Germinal center phenotype and bc1-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lympho-ma", Blood, 99(4), 1136 — 1143.
  • Ree, Hi., Yang, W.I., Kim, C.W., Huh, J., Lee, S.S., Cho, E.Y., et al. (2001) "Coexpression of Bc1-6 and CD10 in diffuse large B-cell lymphomas: significance of Bc1-6 expression patterns in identifying germinal center B-cell lymphoma", Hum. Pathol., 32(9), 954–962.
  • Huang, J.Z., Sanger, W.G., Greiner, T.C., Staudt, L.M., Weisen-burger, D.D., Pickering, DL., et al. (2002) "The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile", Blood, 99(7), 2285–2290.
  • Tsai, ST., Jin, Y.T. and Wu, T.C. (1995) "Synthesis of PCR-derived, digoxigenin-labeled DNA probes for in situ detection of Epstein-Barr early RNAs in Epstein-Barr virus-infected cells", J. ViroL Methods, 54(1), 67–74.
  • Kamihira, S., Nakashima, S., Fukahori, Y., Toriya, K., Kanamura, M. and Ohta, T. (1990) "[Serological evaluation of human T lymphotropic virus type-I infection in routine hospital samples, especially using serodia.HTLV-I]", Rinsho Byori., 38(7), 783–788.
  • Bunn, PA., Jr. and Lamberg, S.I. (1979) "Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas", Cancer Treat. Rep., 63(4), 725–728.
  • Kaplan, E.L. and Meier, P. (1958) "Nonparametric estimation from incomplete observations", J. Am. Stat. Assoc., 53, 457–481.
  • Gehan, E.A. (1965) "A generalized two-sample Wilcoxon test for doubly censored data", Biometrika, 52(3), 650–653.
  • Barrans, S.L., O'Connor, Si., Evans, P.A., Davies, FE., Owen, R.G., Haynes, A.P., et al. (2002) "Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma", Br. J. Haematol., 117(2), 322–332.
  • Lay, JD., Tsao, C.J., Chen, J.Y., Kadin, M.E. and Su, U. (1997) "Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome", J. Clin. Invest., 100(8), 1969–1979.
  • Su, I.J., Wang, C.H., Cheng, A.L. and Chen, R.L. (1995) "Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management", Leuk. Lymphoma, 19(5-6), 401–406.
  • Chuang, S.S., Lin, C.N. and Li, C.Y. (2000) "Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms", Cancer, 89(7), 1586— 1592.
  • Jaffe, ES., Harris, N.L., Stein, H. and Vardiman, J.W. (editors) (2001) Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon: IARC Press.
  • Jaffe, ES., Krenacs, L. and Raffeld, M. (1997) "Classification of T-cell and NK-cell neoplasms based on the REAL classification", Ann. Oncol., 8(Suppl 2), 17 — 24.
  • Lymphoma Study Group of Japanese Pathologists (2000) "The world health organization classification of malignant lymphomas in Japan: incidence of recently recognized entities", PathoL Int., 50(9), 696— 702.
  • Ohshima, K., Suzumiya, J. and Kikuchi, M. (2002) "The World Health Organization classification of malignant lymphoma: in-cidence and clinical prognosis in HTLV-1-endemic area of Fukuoka", Pathol. Int., 52(1), 1–12.
  • Lee, S.S., Cho, K.J., Kim, C.W. and Kang, Y.K. (1999) "Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms", Histopathology, 35(4), 345— 354.
  • Ko, Y.H., Kim, C.W., Park, CS., Jang, H.K., Lee, S.S., Kim, S.H., et al. (1998) "REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma", Cancer, 83(4), 806–812.
  • Chang, Y.T., Liu, H.N., Chen, C.L. and Chow, K.C. (1998) "Detection of Epstein-Barr virus and HTLV-I in T-cell lymphomas of skin in Taiwan", Am. J. Dermatopathol., 20(3), 250–254.
  • Colomo, L., Lopez-Guillermo, A., Perales, M., Rives, S., Martinez, A., Bosch, F., et al. (2003) "Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma", Blood, 101(1), 78 —84.
  • Chen, P.M., Yang, M.H., Yu, I.T., Lin, J.T., Lin, Y.C., Fan, F.S., et al. (2002) "Low incidence of BCL-6 gene alterations for diffuse large B-cell lymphomas in Taiwan Chinese", Cancer, 94(10), 2635–2644.
  • Bahler, D.W., Aguilera, N.S., Chen, C.C., Abbondanzo, S.L. and Swerdlow, S.H. (2000) "Histological and immunoglobulin VH gene analysis of interfollicular small lymphocytic lymphoma provides evidence for two types", Am. J. Pathol., 157(4), 1063–1070.
  • Klein, U., Rajewsky, K. and Kuppers, R. (1998) "Human immunoglobulin (Ig)M + IgD + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells", J. Exp. Med., 188(9), 1679–1689.
  • Banerjee, M., Mehr, R., Belelovsky, A., Spencer, J. and Dunn-Walters, D.K. (2002) "Age- and tissue-specific differences in human germinal center B cell selection revealed by analysis of IgVH gene hypermutation and lineage trees", Eur. J. Immunol., 32(7), 1947–1957.
  • Hsieh, AT., Ho, CL., Chen, Y.C., Kao, W.Y. and Chao, T.Y. (2002) "Epstein-Barr virus and lymphoid hematological disorders", Zhonghua Yi Xue Za Zhi (Taipei), 65(3), 119–123.
  • Liu, S.M., Chow, K.C., Chiu, C.F. and Tzeng, C.H. (1998) "Expression of Epstein-Barr virus in patients with Hodgkin's disease in Taiwan", Cancer, 83(2), 367–371.
  • Cheng, AL., Su, Ii., Chen, Y.C., Uen, W.C. and Wang, C.H. (1993) "Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma", Cancer, 72(3), 909–916.
  • Wang, H., Medeiros, L.J. and Jones, D. (2002) "Subcutaneous panniculitis-like T-cell lymphoma", Clin. Lymphoma, 3(3), 181 — 183.
  • Hamilton-Dutoit, S.J. and Pallesen, G. (1992) "A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas", Am. J. Pathol., 140(6), 1315— 1325.
  • Anagnostopoulos, I., Hummel, M. and Stein, H. (1995) "Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review", Leuk. Lymphoma, 19(1-2), 1–12.
  • Jaffe, ES., Chan, J.K., Su, I.J., Frizzera, G., Mori, S., Feller, A.C. and Ho, F.C. (1996) "Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lympho-mas. Definitions, differential diagnosis, and epidemiology", Am. J. Surg. Pathol., 20(1), 103 — 111.
  • Jaffe, E.S. (1995) Surgical Pathology of the Lymph Nodes and Related Organs. 2nd edn. Philadelphia: W.B. Saunders.
  • Ohshima, K., Haraokaa, S., Ishihara, S., Ohgami, A., Yoshioka, S., Suzumiya, J., et al. (2002) "Analysis of chromosome 6q deletion in EBV-associated NK cell leukaemia/lymphoma", Leuk. Lymphoma, 43(2), 293–300.
  • Sun, H.S., Su, Ii., Lin, Y.C., Chen, J.S. and Fang, S.Y. (2003) "A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural lciller/T-cell lymphoma", Br. J. Haematol., 122(4), 590— 599.
  • Wong, K.F., Chan, J.K. and Kwong, Y.L. (1997) "Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemia", Br. J. Haematol., 98(4), 922–926.
  • Jaffe, E.S. (1995) Surgical Pathology of the Lymph Nodes and Related Organs. 2nd edn. Philadelphia: W.B. Saunders.
  • Gonzalez, CL., Medeiros, Li., Braziel, R.M. and Jaffe, E.S. (1991) "T-cell lymphoma involving subcutaneous tissue. A clinicopatho-logic entity commonly associated with hemophagocytic syndrome", Am. J. Surg. Pathol., 15(1), 17–27.
  • Alizadeh, A.A., Eisen, MB., Davis, RE., Ma, C., Lossos, IS., Rosenwald, A., et al. (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling", Nature, 403(6769), 503 — 511.
  • Gascoyne, RD., Adomat, S.A., Krajewslci, S., Krajewska, M., Horsman, D.E., Tolcher, A.W., et al. (1997) "Prognostic signifi-cance of Bc1-2 protein expression and Bc1-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma", Blood, 90(1), 244 — 251.
  • Geelen, F.A., Vermeer, M.H., Meijer, CJ., Van der Putte, S.C., Kerkhof, E., Kluin, P.M., et al. (1998) "bc1-2 protein expression in primary cutaneous large B-cell lymphoma is site-related", J .Clin. Oncol., 16(6), 2080–2085.
  • The Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) "National Cancer Institute sponsored study of classifications of non- Hodgkin's lymphomas: summary and description of a working formulation for clinical usage", Cancer, 49(10), 2112 — 2135.
  • Engelhard, M., Brittinger, G., Huhn, D., Gerhartz, H.H., Meusers, P., Siegert, W., et al. (1997) "Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor", Blood, 89(7), 2291–2297.
  • Kwak, LW., Wilson, M., Weiss, L.M., Horning, Si., Warnke, R.A. and Dorfman, R.F. (1991) "Clinical significance of morphologic subdivision in diffuse large cell lymphoma", Cancer, 68(9), 1988 — 1993.
  • Nathwani, B.N., Dixon, DO., Jones, SE., Hartsock, R.J., Rebuck, J.W., Byrne, G.E., Jr., et al. (1982) "The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology Group", Blood, 60(5), 1068–1074.
  • Cogliatti, S.B., Schmid, U., Schumacher, U., Eckert, F., Hansmann, ML., Hedderich, J., et al. (1991) "Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients", Gastroenterology, 101(5), 1159 — 1170.
  • Li, G., Hansmann, ML., Zwingers, T. and Lennert, K. (1990) "Primary lymphomas of the lung: morphological, immunohisto-chemical and clinical features", Histopathology, 16(6), 519–531.
  • Wotherspoon, AC., Doglioni, C., Diss, T.C., Pan, L., Moschini, A., de Boni, M., et al. (1993) "Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori", Lancet, 342(8871), 575–577.
  • Montalban, C., Manzanal, A., Boixeda, D., Redondo, C., Alvarez, I., Calleja, J.L., et al. (1997) "Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies", Ann. Oncol., 8(Suppl 2), 37–39.
  • Isaacson, P.G. (1998) Lymphoproliferative disorders of the gastro-intestinal tract. In Pathology of the Gastrointestinal Tract, edited by S.C. Ming and H. Goldman. Pp. 339–359. Baltimore: Williams & Wilkins.
  • Duggan, Mi., Weisenburger, D.D., Ye, Y.L., Bast, M.A., Pierson, J.L., Linder, J., et al. (1990) "Mantle zone lymphoma. A clinicopathologic study of 22 cases", Cancer, 66(3), 522— 529.
  • Pittaluga, S., Wlodarska, I., Stul, M.S., Thomas, J., Verhoef, G., Cassiman, ii., et al. (1995) "Mantle cell lymphoma: a clinico-pathological study of 55 cases", Histopathology, 26(1), 17–24.
  • The Non-Hodgkin's Lymphoma Classification Project (1997) "A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma", Blood, 89(11), 3909 — 3918.
  • Fisher, RI., Dahlberg, S., Nathwani, B.N., Banks, P.M., Miller, T.P. and Grogan, T.M. (1995) "A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study", Blood, 85(4), 1075–1082.
  • Bosch, F., Lopez-Guillermo, A., Campo, E., Ribera, J.M., Conde, E., Piris, M.A., et al. (1998) "Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors", Cancer, 82(3), 567–575.
  • The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) "A predictive model for aggressive non-Hodgkin's lymphoma", N. EngL J. Med., 329(14), 987–994.
  • Armitage, J.O. and Weisenburger, D.D. (1998) "New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project", J. Clin. Oncol., 16(8), 2780–2795.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.